Product Description
Mechanisms of Action: N/A
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: Bulgaria | Chile | China | Colombia | Croatia | Czech | Hong Kong | Hungary | India | Italy | Lithuania | Mexico | Pakistan | Peru | Poland | Russia | Slovakia | Taiwan | Turkey | Ukraine | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: Jiangsu Zhengrui Pharmaceutical Technology Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Phase 3: Trichomonas Infections
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
CTR20243128 | N/A |
Unknown |
Candidiasis, Vulvovaginal |
None |
|
CTR20232737 | P3 |
Unknown Status |
Trichomonas Infections |
None |